0

Purchase Short-Term Access

Additional Factors That Could Improve Cost-Effectiveness of Pharmacogenetic-Guided Dosing in Warfarin Therapy
Benjamin P. Geisler, MD; Jeffrey K. Levin-Scherz, MD, MBA
Annals of Internal Medicine 2009;151:71. doi:10.7326/0003-4819-151-1-200907070-00016

Purchase Online access to this article for 24 hours
Buy Now
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)